Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

661
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
661
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

772
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

732
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.9K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

463
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
463
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

2.7K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in the Overall Incidence and Mortality of Lung Cancer: An Extensive Longitudinal Study Utilizing the CDC WONDER Database 1999-2020.

Thoracic cancer·2026
Same author

Heparin Exposure Adjustment to Reduce Thrombo-hemorrhagic Complications After Venoarterial Extracorporeal Membrane Oxygenator Cannulation: The HEART-ECMO Observational Cohort Study.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

On-scene selective brain cooling in ventricular fibrillation cardiac arrest: pilot results from the PRINCESS2 randomised trial.

Critical care (London, England)·2026
Same author

Late thrombosis of a left atrial appendage occlusion in a patient with cancer.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026
Same author

ESC cardio-oncology conference hits the ground running.

European heart journal·2025
Same author

Percutaneous decannulation of peripheral veno-arterial extracorporeal membrane oxygenation using the Manta closure device.

REC, interventional cardiology·2025

Related Experiment Video

Updated: Apr 6, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.5K

Cardiotoxicity from the cardiologist's perspective.

Juan Caro Codón1, Sandra O Rosillo Rodríguez1, Teresa López Fernández1

  • 1Cardio Oncology Unit, La Paz University Hospital, IdiPaz Research Institute, Madrid, Spain.

Future Cardiology
|August 4, 2015
PubMed
Summary
This summary is machine-generated.

Cancer treatments like chemotherapy and radiotherapy can harm the heart, impacting survivors' quality of life. Early cardiac evaluation and expert cardiology referral are crucial for managing treatment-related cardiac toxicity.

Keywords:
anthracyclinesbiomarkerscardiotoxicitychemotherapydiagnosisechocardiographyglobal longitudinal strainradiotherapytrastuzumab

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.5K
High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 6, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.5K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.5K
High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.6K

Area of Science:

  • Cardiology
  • Oncology
  • Cardio-oncology

Background:

  • Multidisciplinary cancer care improves oncologic patient outcomes and survival rates.
  • Treatment-related cardiac toxicity is a significant adverse effect impacting cancer survivors' quality of life and prognosis.
  • Familiarity with cardiac effects of cancer therapies and diagnostic tools is essential for physicians.

Purpose of the Study:

  • To review the mechanisms of cancer treatment-induced cardiotoxicity.
  • To discuss diagnostic techniques for cardiac evaluation in cancer patients.
  • To emphasize the importance of early diagnosis and specialized cardiology referral.

Main Methods:

  • Review of current literature on cancer treatment mechanisms and cardiac side effects.
  • Discussion of diagnostic modalities including basic and advanced cardiac imaging.
  • Highlighting the role of biomarkers in early detection of cardiac dysfunction.

Main Results:

  • Chemotherapy and radiotherapy can lead to significant cardiac toxicity.
  • Various imaging techniques and biomarkers aid in the early detection of cardiac damage.
  • Prompt referral to specialized cardio-oncology units improves patient management.

Conclusions:

  • Understanding cardiotoxicity mechanisms is vital for oncologic patient care.
  • Comprehensive cardiac evaluation utilizing imaging and biomarkers facilitates early diagnosis.
  • Integrated care involving cardiologists is essential for managing cancer survivors' cardiac health.